SIX1 and PAI-1 emerge as therapeutic targets in systemic sclerosis
Crossref DOI link: https://doi.org/10.1038/s41584-026-01367-5
Published Online: 2026-03-12
Published Print: 2026-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Onuora, Sarah
Text and Data Mining valid from 2026-03-12
Version of Record valid from 2026-03-12
Article History
First Online: 12 March 2026